We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PFE market cap is 126.1B. The company's latest EPS is USD 1.4171 and P/E is 15.62.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 14.25B | 14.88B | 13.28B | 17.7B | 17.76B |
| Operating Income | -7.48B | 4.01B | 1.04B | 5.11B | -947M |
| Net Income | -3.37B | 3.12B | 41M | 4.47B | 410M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41.91B | 81.29B | 100.33B | 58.5B | 63.63B |
| Operating Income | 6.77B | 19.82B | 34.96B | -2.3B | 9.22B |
| Net Income | 9.62B | 21.98B | 31.37B | 2.12B | 8.03B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 226.5B | 221.1B | 216.19B | 219.48B | 213.4B |
| Total Liabilities | 137.21B | 128.54B | 128.22B | 126.92B | 124.9B |
| Total Equity | 89.29B | 92.56B | 87.98B | 92.56B | 88.5B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 154.23B | 181.48B | 197.21B | 226.5B | 213.4B |
| Total Liabilities | 90.76B | 104.01B | 101.29B | 137.21B | 124.9B |
| Total Equity | 63.47B | 77.46B | 95.92B | 89.29B | 88.5B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 8.7B | 1.09B | -690M | 6.02B | 12.74B |
| Investing | -32.28B | 1.73B | 6.33B | 4.28B | 2.65B |
| Financing | 26.07B | -4.93B | -7.39B | -12.03B | -17.14B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 14.4B | 32.58B | 29.27B | 8.7B | 12.74B |
| Investing | -4.27B | -22.55B | -15.78B | -32.28B | 2.65B |
| Financing | -9.65B | -9.82B | -14.83B | 26.07B | -17.14B |
| Market Cap | 126.1B |
| Price to Earnings Ratio | 15.62 |
| Price to Sales Ratio | 1.97 |
| Price to Cash Ratio | 120.33 |
| Price to Book Ratio | 1.42 |
| Dividend Yield | 7.73% |
| Shares Outstanding | 5.67B |
| Average Volume (1 week) | 55.46M |
| Average Volume (1 Month) | 70.86M |
| 52 Week Change | -13.39% |
| 52 Week High | 31.54 |
| 52 Week Low | 20.915 |
| Spread (Intraday) | 0.03 (0.13%) |
| Company Name | Pfizer Inc |
| Address |
235 east 42nd street new york, new york 10017 |
| Website | https://www.pfizer.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
